The Latest Breaking News from JAMA

Researchers trumpeted a statistically insignificant finding and attempted to explain away contrary data. The Gray Lady further garbled the evidence.

Heart valves transplanted as part of the first partial-heart transplant in a human are now growing along with the infant who received them.

A study suggests that using cannabis in pregnancy may raise the risk of pregnancy outcomes that are linked to placental dysfunction.

Khan says a recent Federal Trade Commission lawsuit is meant to chill the consolidation of medical groups that results in higher prices for consumers. But it may be too late to curb price hikes.

Honda, Kawasaki, Suzuki, Yamaha, and Toyota (yes, we said Toyota) have some exciting concepts and other things to show off at the 2023 Japan Mobility Show.

Eli Lilly & Co. said it applied for full U.S. approval of its Alzheimer’s disease drug that’s expected to compete with Eisai Co.’s Leqembi as the U.S. drugmaker revealed details of a final-stage trial at a conference in Amsterdam.

New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening

The rate at which women in the U.S. are dying from pregnancy related causes more than doubled in recent decades. A new study, published in JAMA shows Black women and Native Americans are most at risk.

A study from researchers at Johns Hopkins is the first to look at the effects of Texas' 2021 "Heartbeat Act" on live births.

The Japan Automobile Manufacturers Association (JAMA) held an exhibition featuring decarbonized vehicles in Hiroshima during the recent summit of the Group of Seven nations. It exhibited 35 models including electric vehicles (EVs) and hydrogen vehicles, emphasizing various decarbonization technologies.

A new study published in JAMA has shown the horrific health inequalities black Americans in the US faced compared to the White population from 1999 to 2020.